Formosa Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	273.17	241.79	425.79	384.71	267.34	208.92
Short-Term Investments	1,110	1,200	1,220	831.41	153.55	-
Cash & Short-Term Investments	1,383	1,442	1,646	1,216	420.89	208.92
Cash Growth	-13.27%	-12.39%	35.33%	188.94%	101.46%	398.99%
Other Receivables	12.6	25.7	51.66	46.44	14.72	13.88
Receivables	39.1	25.7	51.66	46.44	14.72	13.88
Inventory	4.77	4.17	2.89	-	-	-
Prepaid Expenses	58.7	44.12	26.94	25.34	20.57	11.66
Other Current Assets	1.43	0.16	0.52	0.44	0.13	0.04
Total Current Assets	1,487	1,516	1,728	1,288	456.31	234.5
Property, Plant & Equipment	40.96	43.56	29.89	34.36	10.18	8.19
Long-Term Investments	1.52	1.54	5.15	27.26	-	-
Goodwill	-	30.54	30.54	30.54	30.54	30.54
Other Intangible Assets	451.85	431.77	311.85	345.64	380.2	414.83
Other Long-Term Assets	48.94	47.89	7.05	0.65	0.67	0.65
Total Assets	2,030	2,071	2,112	1,727	877.91	688.72
Accounts Payable	2.61	0.77	-	-	-	-
Accrued Expenses	7.51	89.74	128.36	86.67	66.09	7.17
Current Portion of Leases	5.86	6.57	5.5	5.5	2.5	2.76
Current Unearned Revenue	3.52	21.29	4.51	71.33	-	-
Other Current Liabilities	109.78	48.04	59.59	94.48	0.98	9.37
Total Current Liabilities	129.27	166.42	197.95	257.98	69.57	19.3
Long-Term Leases	19.46	20.41	20.3	24.29	4.41	0.42
Long-Term Unearned Revenue	22.24	16.76	23.48	1.66	-	-
Long-Term Deferred Tax Liabilities	3.33	3.46	3.95	4.45	4.94	5.43
Other Long-Term Liabilities	414.34	407.02	318.02	297.84	331.6	270.33
Total Liabilities	588.64	614.06	563.7	586.21	410.51	295.48
Common Stock	1,510	1,510	1,510	1,341	1,136	988.32
Additional Paid-In Capital	2,279	2,279	2,279	1,780	978.52	620.49
Retained Earnings	-2,252	-2,237	-2,153	-1,952	-1,630	-1,202
Comprehensive Income & Other	-95.93	-95.74	-87.59	-29.91	-18.14	-14.53
Total Common Equity	1,441	1,457	1,548	1,140	466.83	392.74
Minority Interest	0.56	0.55	0.59	0.54	0.57	0.49
Shareholders' Equity	1,442	1,457	1,549	1,141	467.4	393.23
Total Liabilities & Equity	2,030	2,071	2,112	1,727	877.91	688.72
Total Debt	25.32	26.99	25.8	29.79	6.9	3.18
Net Cash (Debt)	1,358	1,415	1,620	1,186	413.99	205.74
Net Cash Growth	-13.53%	-12.67%	36.55%	186.56%	101.22%	476.99%
Net Cash Per Share	8.99	9.37	11.50	9.56	3.94	2.22
Filing Date Shares Outstanding	150.98	150.98	150.98	134.14	113.64	98.83
Total Common Shares Outstanding	150.98	150.98	150.98	134.14	113.64	98.83
Working Capital	1,358	1,350	1,530	1,030	386.75	215.2
Book Value Per Share	9.55	9.65	10.25	8.50	4.11	3.97
Tangible Book Value	989.39	994.31	1,206	763.85	56.09	-52.64
Tangible Book Value Per Share	6.55	6.59	7.99	5.69	0.49	-0.53
Machinery	-	23.76	8.14	7.38	7.44	7.44
Leasehold Improvements	-	0.7	0.7	0.45	1.54	1.54